Clinical study of immune-targeting combined with attenuated chemotherapy in the treatment of children with classic Hodgkin lymphoma
Objective: To evaluate the efficacy and safety of brentuximab vedotin (BV) combined with rituximab and attenuated chemotherapy in the treatment of children with classic Hodgkin lymphoma (cHL). Methods: A prospective, non-randomized, risk-assigned study. Clinical data (including age, gender, B sympto...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 62(2024), 11 vom: 02. Nov., Seite 1097-1102
|
|---|
| 1. Verfasser: |
Gao, H X
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Li, Y,
Li, N,
Huang, S,
Zhang, M,
Zhou, C J,
Zhang, N N,
Zhang, Y M,
Yang, J,
Jin, L,
Wang, X L,
Wang, T Y,
Duan, Y L |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Chinese |
|---|
| Veröffentlicht: |
2024
|
|---|
| Zugriff auf das übergeordnete Werk: | Zhonghua er ke za zhi = Chinese journal of pediatrics
|
|---|
| Schlagworte: | English Abstract
Journal Article
Rituximab
4F4X42SYQ6 |
|---|